To focus on changes occurring specifically in myeloid and neoplastic cells, we performed spatial transcriptomics analysis on GFAP+ cells (tumor cells, astrocytes) and CD64+ cells to gain a more granular understanding of myeloid/tumor transcriptional state changes on the path from pGBM to rGBM. This evidence concerns the gene FCGR1A and neoplasm.